The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan

Int J Cancer. 1989 Jun 15;43(6):970-4. doi: 10.1002/ijc.2910430603.

Abstract

A gene product (p42) of the long open reading frame, now termed tax, of the viral genome of human T-cell leukemia virus type I (HTLV-I) may be related to the transformation of T cells in adult T-cell leukemia-lymphoma (ATLL). To evaluate its association with the disease, we compared the prevalence of antibody to p42 in sera obtained from 105 HTLV-I carriers and 64 ATLL patients from southwest Japan. The prevalence of the anti-p42 antibody reactivity was 63% among carriers and 31% among cases. The cases were more than 3 times as likely to lack antibody to p42 than carriers, the relative odds (OR) = 3.4, p = 0.001. When the samples were tested for antibody against p24, the most immunogenic core protein, the prevalence was somewhat higher among carriers (65%) than in cases (52%), but not significantly so (p = 0.15). Among the healthy carriers, the correlation between the prevalence of both antibodies was high (p = 0.001), and only 25% of those who had antibody to p24 lacked antibody to p42. However, among the cases, reactivity to both antigens was independent (p = 0.52), and 65% of those with antibody to p24 lacked antibody to p42, OR = 6.3, p = 0.0004. Thus the strongest serologic marker of ATLL following diagnosis was lack of reactivity to p42, particularly among those subjects with anti-p24. Whether this altered response is present prior to disease remains to be determined.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Autoradiography
  • Carrier State / epidemiology
  • Carrier State / immunology*
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • HTLV-I Antibodies / analysis*
  • HTLV-I Antigens / analysis
  • HTLV-I Antigens / immunology*
  • Humans
  • Japan
  • Leukemia-Lymphoma, Adult T-Cell / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / immunology*
  • Male
  • Middle Aged
  • Precipitin Tests
  • Trans-Activators
  • Transcription Factors / analysis
  • Transcription Factors / immunology*

Substances

  • HTLV-I Antibodies
  • HTLV-I Antigens
  • Trans-Activators
  • Transcription Factors